ICU Medical (NASDAQ:ICUI) Shares Pass Above 200 Day Moving Average - Here's Why

Shares of ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $157.00 and traded as high as $162.01. ICU Medical shares last traded at $160.99, with a volume of 133,187 shares changing hands.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on ICUI shares. Raymond James upped their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research note on Thursday, September 12th. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, November 20th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research note on Wednesday, November 13th. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price for the company in a research note on Wednesday, December 11th. Finally, KeyCorp upped their price objective on ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research note on Wednesday, November 13th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $199.67.

ICU Medical Price Performance

The stock's fifty day moving average price is $163.34 and its 200-day moving average price is $157.00. The firm has a market cap of $3.78 billion, a price-to-earnings ratio of -33.77 and a beta of 0.63. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

Insider Buying and Selling

In other ICU Medical news, Director David C. Greenberg sold 972 shares of the company's stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total transaction of $153,682.92. Following the transaction, the director now owns 5,037 shares of the company's stock, valued at approximately $796,400.07. This represents a 16.18 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction that occurred on Friday, November 1st. The stock was sold at an average price of $171.84, for a total transaction of $2,062,080.00. Following the sale, the chief executive officer now owns 104,593 shares of the company's stock, valued at approximately $17,973,261.12. This represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 29,737 shares of company stock worth $4,941,832. Insiders own 6.70% of the company's stock.

Institutional Investors Weigh In On ICU Medical

Several institutional investors have recently added to or reduced their stakes in ICUI. Diversified Trust Co grew its stake in shares of ICU Medical by 32.3% in the fourth quarter. Diversified Trust Co now owns 3,301 shares of the medical instruments supplier's stock valued at $512,000 after buying an additional 805 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of ICU Medical by 24.6% in the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock worth $23,130,000 after purchasing an additional 25,031 shares during the period. Franklin Resources Inc. lifted its holdings in shares of ICU Medical by 99.3% during the 3rd quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier's stock worth $2,111,000 after acquiring an additional 5,834 shares during the period. Coldstream Capital Management Inc. acquired a new stake in shares of ICU Medical in the 3rd quarter valued at $227,000. Finally, Geode Capital Management LLC grew its position in ICU Medical by 9.6% in the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock valued at $99,687,000 after acquiring an additional 48,106 shares during the last quarter. 96.10% of the stock is owned by institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.